Wells Fargo & Company Frequency Therapeutics, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.35 - $0.72 $3 - $6	9 Added 1.48%	617 $0
Q2 2023 Aug 15, 2023	BUY	$0.33 - $0.48 $4 - $6	14 Added 2.36%	608 $0
Q1 2023 May 12, 2023	BUY	$0.44 - $5.47 $1 - $21	4 Added 0.68%	594 $0
Q4 2022 Feb 13, 2023	BUY	$1.88 - $3.85 $11 - $23	6 Added 1.03%	590 $2,000
Q3 2022 Nov 14, 2022	BUY	$1.46 - $2.55 $37 - $66	26 Added 4.66%	584 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.03 - $2.03 $3,346 - $6,595	-3,249 Reduced 85.34%	558 $1,000
Q1 2022 May 16, 2022	SELL	$1.7 - $5.72 $19,024 - $64,012	-11,191 Reduced 74.62%	3,807 $8,000
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $72,393 - $103,983	14,625 Added 3920.91%	14,998 $77,000
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $106,780 - $141,913	-15,342 Reduced 97.63%	373 $2,000
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $54,788 - $79,017	-6,806 Reduced 30.22%	15,715 $156,000
Q1 2021 May 13, 2021	SELL	$7.99 - $55.01 $288,159 - $1.98 Million	-36,065 Reduced 61.56%	22,521 $213,000
Q4 2020 Feb 09, 2021	BUY	$18.65 - $40.0 $72,548 - $155,600	3,890 Added 7.11%	58,586 $2.07 Million
Q3 2020 Nov 05, 2020	BUY	$17.76 - $24.96 $9,750 - $13,703	549 Added 1.01%	54,696 $1.05 Million
Q2 2020 Aug 13, 2020	BUY	$14.65 - $24.9 $720,530 - $1.22 Million	49,183 Added 990.79%	54,147 $1.26 Million
Q1 2020 May 14, 2020	BUY	$16.36 - $27.55 $81,211 - $136,758	4,964 New	4,964 $88,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.